ARCHIVES

Oral Complications Reduced By Pretherapy NIH Conference Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 17 | April 28, 1989

Download PDF Visit The Full Archive

Related Articles

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994